CIK 0001708527
- Non-accelerated filer
- Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474790334
- Phone
- +1 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-03 | HighCape Capital, L.P. Director | Purchase | +420,000 | $2.50 | $1.1M | 9,520,232 |
| 2025-02-03 | HighCape Capital, L.P. Director | Purchase | +420,000 | $2.50 | $1.1M | 9,520,232 |
| 2024-07-30 | HighCape Capital, L.P. Director | Option exercise | +2,101,577 | $1.43 | $3.0M | 9,100,232 |
| 2024-07-30 | HighCape Capital, L.P. Director | Option exercise · Warrants (right to buy) | −2,101,577 | 0 | ||
| 2023-12-28 | HighCape Capital, L.P. Director | Other disposition | −1,436,077 | 6,998,655 | ||
| 2023-12-28 | HighCape Capital, L.P. Director | Other disposition · Warrants (right to buy) | −2,154,116 | 2,101,577 | ||
| 2023-06-08 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2023-06-08 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-12-22 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +17,533 | 17,533 | ||
| 2022-12-05 | HighCape Capital, L.P. Director | Purchase | +735,000 | $4.75 | $3.5M | 5,597,604 |
| 2022-06-07 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +22,090 | 22,090 | ||
| 2022-06-07 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +22,090 | 22,090 | ||
| 2021-12-08 | HighCape Capital, L.P. Director | Purchase | +353,773 | $4.24 | $1.5M | 4,862,604 |
| 2021-12-08 | HighCape Capital, L.P. Director | Purchase | +58,962 | $4.24 | $250K | 90,807 |
| 2021-09-21 | HighCape Capital, L.P. Director | Purchase | +2,837,128 | 8,434,732 | ||
| 2021-09-21 | HighCape Capital, L.P. Director | Purchase · Warrants (right to buy) | +4,255,693 | 4,255,693 | ||
| 2021-06-07 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +14,082 | 14,082 | ||
| 2021-06-07 | HighCape Capital, L.P. Director | Grant or award · Stock Option (Right to Buy) | +14,082 | 14,082 | ||
| 2020-10-13 | HighCape Capital, L.P. 10% owner | Conversion | +4,062,451 | 4,062,451 | ||
| 2020-10-13 | HighCape Capital, L.P. 10% owner | Option exercise | +7,655 | $5.44 | $42K | 4,070,106 |
Page 1 of 2 · 24 trades